Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma
{{output}}
Background: Lymphoma is a common hematologic malignancy with limited treatment options. The research objective was to ascertain plasma proteins that could be targeted for lymphoma treatment. ... ...